Actively Recruiting

Phase 3
Age: 7Years - 18Years
All Genders
NCT05681572

Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia

Led by University Hospital, Montpellier · Updated on 2024-12-16

1000

Participants Needed

1

Research Sites

234 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Children undergoing general anesthesia for surgery commonly need sedative and anxiolytic premedication but little clinical evidence supports is benefit for children older than 7 years old. The aim of this prospective randomized clinical trial is to assess the impact of pharmacologic premedication on perioperative children experience.

CONDITIONS

Official Title

Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia

Who Can Participate

Age: 7Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject over 7 and under 18 years of age
  • Scheduled for surgery
  • Will be under general anesthesia
  • Able to complete a self-questionnaire in French
Not Eligible

You will not qualify if you...

  • Previously participated in the pediaPREM study
  • Treated anxiety disorder
  • Cognitive disorders
  • Chronic pain outside the operated area
  • Attention Deficit Disorder with or without hyperactivity or treatment
  • Mental retardation
  • Receiving psychotropic treatment
  • Intervention reducing ability to complete self-questionnaire (e.g., neurosurgery)
  • Contraindication to midazolam or its excipients
  • Contraindication to dexmedetomidine or its excipients
  • Need for intravenous alpha agonist perioperatively
  • Emergency intervention required
  • Require preoperative hypnosis
  • General anesthesia for diagnostic purposes (e.g., biopsy)
  • Surgery within one month before inclusion
  • Iterative surgical intervention within 15 days (e.g., removal of material, burns)
  • Surgery as part of oncology management
  • Pregnant or breastfeeding woman
  • Parents have not signed written informed consent
  • Not affiliated with or benefiting from a social security plan

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Uhmontpellier

Montpellier, France, 34295

Actively Recruiting

Loading map...

Research Team

S

Sophie BRINGUIER, PHD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here